PHAR vs VRTX: Which Stock is Better?
Side-by-side comparison of Pharming Group NV and Vertex Pharmaceuticals Inc in 2026
PHAR
Pharming Group NV
—
VRTX
Vertex Pharmaceuticals Inc
$486.03
Key Metrics Comparison
| Metric | PHAR | VRTX | Winner |
|---|---|---|---|
| Market Cap | $723.60M | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAR
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or VRTX a better investment?
Comparing PHAR and VRTX: Pharming Group NV has a market cap of $723.60M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and VRTX?
PHAR (Pharming Group NV) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAR or VRTX?
Both PHAR and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAR or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAR or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $723.60M for PHAR.
Should I buy PHAR or VRTX in 2026?
Both PHAR and VRTX have investment merit. PHAR trades at $N/A while VRTX trades at $486.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and VRTX stock?
Key differences: Market Cap ($723.60M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAR or VRTX in 2026?
The choice between PHAR and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAR and VRTX?
PHAR (Pharming Group NV) has a market cap of $723.60M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.